Dementia: assessment, management and support for people living with dementia and their carers

Update information

June 2018: This guideline is an update of the NICE guideline on dementia (CG42, published November 2006) and replaces it. It also replaces recommendation 1.3 in the NICE technology appraisal guidance on donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease.

Minor changes since publication

June 2025: We amended recommendation 1.8.11 on eye tests to ensure problems with eyesight are identified soon after a diagnosis of dementia to help reduce risk of falls and improve quality of life.

April 2025: We updated the links to safety advice from the Medicines and Healthcare products Regulatory Agency (MHRA) in recommendation 1.7.10.

October 2021: We have linked to the NICE guideline on supporting adult carers in recommendation 1.11.4.

October 2018: Links have been added to patient decision aids from some recommendations.

ISBN: 978-1-4731-2978-8